Product Theater

ERLEADA® (apalutamide)—For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) | Sponsored By: Janssen

Speaker(s)

• CP

  Christopher M. Pieczonka, MD
• 

  Robert Evan Reiter, MD

  UCLA
• AB

  Aaron D. Berger, MD

  Chief Medical Officer and Director of Clinical Research